ZZ Top's Drummer Frank Beard Takes Leave for Health Reasons
March 17, 2025 - 15:31
ZZ Top's longtime drummer Frank Beard has announced a leave of absence due to the need to undergo an unspecified health procedure. The news comes as a surprise to fans of the iconic rock band, known for their distinctive sound and energetic performances. Beard, who has been with the band since its inception in 1969, has played a crucial role in shaping their musical identity.
While details about the health issue remain private, Beard expressed his gratitude for the support of fans and fellow band members during this time. The drummer's absence is expected to impact the band's upcoming tour schedule, prompting questions about how ZZ Top will continue to perform without one of its founding members.
Fans are hopeful for a swift recovery for Beard, who has been a beloved figure in the music industry for decades. As the band navigates this challenging period, they remain committed to their music and the loyal fanbase that has supported them through thick and thin.
MORE NEWS
September 14, 2025 - 02:22
John Abraham Discusses Lake Health at Minnesota State FairJohn Abraham, a professor of mechanical engineering, recently appeared on WCCO Radio during the Minnesota State Fair, where he engaged in a conversation with hosts Adam Carter and Jordana Green....
September 13, 2025 - 01:39
Vaccine Advisory Committee to Review Covid Shot Data Next WeekThe vaccine advisory committee is set to convene next week to evaluate and make recommendations regarding the updated Covid shots for the upcoming fall season. This meeting comes at a time when...
September 12, 2025 - 02:37
Exploring the Future of Women's Health ResearchWhile we understand more about women’s health than ever before, critical gaps remain. How can we delve deeper into the lifestyle and genetic factors that influence women`s health outcomes? As we...
September 11, 2025 - 01:12
New FDA Regulations Target Compounded GLP-1 Medications While Apple Expands Health FeaturesThe FDA has announced new regulations aimed at addressing the rising popularity of compounded GLP-1 medications, which have gained traction as effective treatments for obesity and diabetes. These...